Fall COVID-19 wave or winter coronavirus surge with Andrea Garcia, JD, MPH – American Medical Association

by | Oct 5, 2022 | COVID-19

AMA Update covers a range of health care topics affecting the lives of physicians, residents, medical students and patients. From private practice and health system leaders to scientists and public health officials, hear from the experts inĀ medicineĀ on COVID-19, monkeypox, medical education, advocacy issues, burnout, vaccines and more.

Featured topic and speakers
Featured topic and speakers

AMA’s vice president of science, medicine and public health, Andrea Garcia, JD, MPH discusses the latest from the CDC on monkeypox treatments and universal masking guidelines for health care settings. Also covering new Omicron boosters and “most resistant variant” emerging in the UK. AMA Chief Experience Officer Todd Unger hosts.

Learn more at the AMA COVID-19 resource center.


Andrea Garcia, JD, MPH, vice president, science, medicine & public health, American Medical Association


Unger: Hello and welcome to the AMA Update video and podcast, an ongoing series covering a range of health care topics affecting the lives of physicians and patients. Today, we have our weekly look at the headlines with AMA’s Vice President of Science, Medicine and Public Health Andrea Garcia in Chicago. I’m Todd Unger, AMA’s chief experience officer, also in Chicago.

Andrea, let’s start off by talking about the new bivalent booster. Word on the street is the uptake is on the slow side. Is that the truth?

Garcia: Yeah, well, reports have suggested that the updated boosters are having a visibility problem and that’s according to a recent report by the Kaiser Family Foundation. By mid- to late September, nearly half of adults had heard little to nothing about these new boosters and I thi …

Article Attribution | Read More at Article Source

Share This